FDA-Drug2026-07-29Class IIPROCESSING DEFECT

Rohto Cooling Eye Drops Max Strength recalled for lack of sterility assurance

OTHERNationwide distribution

Rohto Cooling Eye Drops Max Strength recalled for sterility concerns

Rohto Cooling Eye Drops Max Strength (a nasal decongestant eye drop product) was distributed without assurance that all units met sterility standards. The product is used directly in the eye, where any contamination could pose a risk of infection. This recall affects specific lot numbers distributed nationwide.

  • Check the lot number on your Rohto Cooling Eye Drops Max Strength twin pack against the list provided (3H1V through 6C2V with various expiration dates through 2029).
  • Do not use the product if your lot number matches any on the recall list.
  • Contact Mentholatum Company or your retailer for instructions on disposal or replacement.
  • If you have used this product and experience eye redness, irritation, or discharge, contact your eye care provider.
Hazard

Lack of Assurance of Sterility

Sold states
Nationwide within the United States
Affected count
499,673 cartons
Manufactured in
No. 16 Vsip, Street No. 5, Vietnam Singapore Industrial Park, Ho Chi Minh, N/A, Vietnam
Products
Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%), Sterile, TWIN PACK, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011210, NDC 10742-8158-2

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0717-2026

More Rohto-Mentholatum (Vietnam) Co., Ltd. recalls

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief